Professor Huang Peng and Professor Zhou Feifan from Shenzhen University were invited to Shenzhen Institutes of Advanced Technology for academic exchanges on June 12, 2019, and delivered academic reports titled "Applications of Glucose Oxidase in Cancer Diagnosis and Treatment" and "Applications of Laser Immunotherapy in the Treatment of Malignant Tumors" respectively. In Professor Huang Peng's report "Applications of Glucose Oxidase in Cancer Diagnosis and Treatment", he mainly introduced the progress and applications in cancer treatment by integrating glucose oxidase (GOx)-mediated tumor starvation-like therapy with other tumor treatment methods. As for Professor Zhou Feifan's report "Applications of Laser Immunotherapy in the Treatment of Malignant Tumors", it mainly combined laser therapy with the integration of immunotherapy, photothermal targeted therapy, and immunotherapy to explore the development and clinical applications of specific anti-tumor laser immunotherapy.

Professor Huang Peng communicated with the teachers and students of Shenzhen Institutes of Advanced Technology

Professor Zhou Feifan communicated with the teachers and students of Shenzhen Institutes of Advanced Technology

Personal Profiles: Huang Peng, Ph.D., is a Distinguished Professor and a Ph.D. supervisor at Shenzhen University. Currently, he serves as the Assistant to the Dean of the School of Medicine at Shenzhen University, the Executive Director of the Marshall Biomedical Engineering Laboratory of Shenzhen University, the Head of the Department of Molecular Imaging at the School of Biomedical Engineering of the School of Medicine, and the Deputy Director of the Youth Committee of Nano Oncology of the Chinese Anti-Cancer Association. He mainly engages in research in the fields of molecular imaging and nanomedicine. To date, he has published more than 150 SCI papers. After returning to Shenzhen University in 2015, he has published more than 80 papers, among which 56 are first-authored or corresponding-authored. These include 1 paper in Nature Biomedical Engineering (a sub-journal of *Nature*), and 27 papers published in journals with an impact factor of more than 10. Many of his papers have been commented on by Nature Photonics, Science Translational Medicine, and Nature Reviews Nephrology. 15 papers have been selected as cover articles, and 10 papers have been included in the top 1% ESI highly cited papers. His papers have been cited more than 9,200 times in total, and his H-index is 55. He has won the Second "Chinese Young Scientist Award in Oncology" (2018), the Shenzhen Youth Science and Technology Award (2018), the Fok Ying Tung Young Teachers Fund (2017), and the National Distinguished Expert (2017). Zhou Feifan, Ph.D., is a Distinguished Professor and a Ph.D. supervisor at Shenzhen University. He mainly focuses on the basic research of the application of laser and nanotechnology in life sciences. This includes the mechanism research of tumor photoimmunotherapy, the development of tumor optical treatment technologies mediated by novel nanoprobes, and the pre-clinical research and clinical application of photoimmunotherapy. He was awarded the National Top 100 Excellent Doctoral Dissertations in 2013 and was selected for the 14th batch of the Youth Program of Overseas High-level Talents by the Organization Department of the Central Committee in 2017. He has published more than 40 SCI papers in internationally renowned journals in the field of biomedical engineering, such as Nano Lett and Clinic Cancer Res, and his papers have been cited more than 2,000 times. He is a member of the Society of Photo-Optical Instrumentation Engineers (SPIE) and a member of the Laser and Immune Response Branch. He is also a member of the Biomedical Photonics Branch of the Chinese Society of Biotechnology.